Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes

Biochemical and Biophysical Research Communications

Volumn 478, Issue 1, 2016, Pages 143-148

  Vogel, Sebastian ^a,b   Rath, Dominik ^a   Borst, Oliver ^a   Mack, Andreas ^a   Loughran, Patricia ^b   Lotze, Michael T ^b   Neal, Matthew D ^b   Billiar, Timothy R ^b   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; High mobility group box 1; Migration; Monocytes; Platelets

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; ADVANCED GLYCATION END PRODUCT RECEPTOR; AGER PROTEIN, MOUSE; HMGB1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL INJURY; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAGE; THROMBOCYTE; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; HMGB1 PROTEIN; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; MONOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 84982740653     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.07.078     Document Type: Article

References (27)

1. [1] Andonegui, G., Trevani, A.S., Lopez, D.H., Raiden, S., Giordano, M., Geffner, J.R., Inhibition of human neutrophil apoptosis by platelets. J. Immunol. 158 (1997), 3372–3377.
2. [2] Gawaz, M., Langer, H., May, A.E., Platelets in inflammation and atherogenesis. J. Clin. Investig. 115 (2005), 3378–3384.
3. [3] Lang, D., Dohle, F., Terstesse, M., Bangen, P., August, C., Pauels, H.G., Heidenreich, S., Down-regulation of monocyte apoptosis by phagocytosis of platelets: involvement of a caspase-9, caspase-3, and heat shock protein 70- dependent pathway. J. Immunol. 168 (2002), 6152–6158.
4. [4] Morrell, C.N., Aggrey, A.A., Chapman, L.M., Modjeski, K.L., Emerging roles for platelets as immune and inflammatory cells. Blood 123 (2014), 2759–2767.
5. [5] Rouhiainen, A., Imai, S., Rauvala, H., Parkkinen, J., Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thrombosis haemostasis 84 (2000), 1087–1094.
6. [6] Vogel, S., Bodenstein, R., Chen, Q., Feil, S., Feil, R., Rheinlaender, J., Schaffer, T.E., Bohn, E., Frick, J.S., Borst, O., Munzer, P., Walker, B., Markel, J., Csanyi, G., Pagano, P.J., Loughran, P., Jessup, M.E., Watkins, S.C., Bullock, G.C., Sperry, J.L., Zuckerbraun, B.S., Billiar, T.R., Lotze, M.T., Gawaz, M., Neal, M.D., Platelet-derived HMGB1 is a critical mediator of thrombosis. J. Clin. Investig. 125 (2015), 4638–4654.
7. [7] Vogel, S., Chatterjee, M., Metzger, K., Borst, O., Geisler, T., Seizer, P., Muller, I., Mack, A., Schumann, S., Buhring, H.J., Lang, F., Sorg, R.V., Langer, H., Gawaz, M., Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J. Biol. Chem. 289 (2014), 11068–11082.
8. [8] Stros, M., HMGB proteins: interactions with DNA and chromatin. Biochimica biophysica acta 1799 (2010), 101–113.
9. [9] Andersson, U., Tracey, K.J., HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29 (2011), 139–162.
10. [10] Ciucci, A., Gabriele, I., Percario, Z.A., Affabris, E., Colizzi, V., Mancino, G., HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity. PLoS One, 6, 2011, e23766.
11. [11] Yang, D., Chen, Q., Yang, H., Tracey, K.J., Bustin, M., Oppenheim, J.J., High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81 (2007), 59–66.
12. [12] Lotfi, R., Herzog, G.I., DeMarco, R.A., Beer-Stolz, D., Lee, J.J., Rubartelli, A., Schrezenmeier, H., Lotze, M.T., Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J. Immunol. 183 (2009), 5023–5031.
13. [13] Zhu, X., Messer, J.S., Wang, Y., Lin, F., Cham, C.M., Chang, J., Billiar, T.R., Lotze, M.T., Boone, D.L., Chang, E.B., Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J. Clin. Investig. 125 (2015), 1098–1110.
14. [14] Vogel, S., Borger, V., Peters, C., Forster, M., Liebfried, P., Metzger, K., Meisel, R., Daubener, W., Trapp, T., Fischer, J.C., Gawaz, M., Sorg, R.V., Necrotic cell- derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ. 22 (2015), 1219–1230.
15. [15] Kierdorf, K., Fritz, G., RAGE regulation and signaling in inflammation and beyond. J. Leukoc. Biol. 94 (2013), 55–68.
16. [16] Visintin, A., Mazzoni, A., Spitzer, J.H., Wyllie, D.H., Dower, S.K., Segal, D.M., Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166 (2001), 249–255.
17. [17] Shi, C., Pamer, E.G., Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11 (2011), 762–774.
18. [18] Kameyoshi, Y., Dorschner, A., Mallet, A.I., Christophers, E., Schroder, J.M., Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176 (1992), 587–592.
19. [19] Nakamura, T., Teramoto, H., Ichihara, A., Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 6489–6493.
20. [20] Beilmann, M., Vande Woude, G.F., Dienes, H.P., Schirmacher, P., Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95 (2000), 3964–3969.
21. [21] Schall, T.J., Bacon, K., Toy, K.J., Goeddel, D.V., Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 (1990), 669–671.
22. [22] Mangan, D.F., Wahl, S.M., Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro- inflammatory cytokines. J. Immunol. 147 (1991), 3408–3412.
23. [23] Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage- Griebenow, E., Brandt, E., Flad, H.D., Petersen, F., The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95 (2000), 1158–1166.
24. [24] Gawaz, M., Vogel, S., Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 122 (2013), 2550–2554.
25. [25] Venet, F., Pachot, A., Debard, A.L., Bohe, J., Bienvenu, J., Lepape, A., Powell, W.S., Monneret, G., Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand- dependent mechanism. J. Immunol. 177 (2006), 6540–6547.
26. [26] Namgaladze, D., Kollas, A., Brune, B., Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling. J. Lipid Res. 49 (2008), 58–65.
27. [27] Barczyk, K., Ehrchen, J., Tenbrock, K., Ahlmann, M., Kneidl, J., Viemann, D., Roth, J., Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood 116 (2010), 446–455.